𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab for severe gastrointestinal bleeding in Crohn's disease

✍ Scribed by Yugo Ando; Mitsunobu Matsushita; Seiji Kawamata; Masaaki Shimatani; Toshihito Fujii; Kazuichi Okazaki

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
116 KB
Volume
15
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Severe agranulocytosis following first i
Severe agranulocytosis following first infliximab infusion in Crohn's disease
✍ JosΓ© Miguel Rosales-ZΓ‘bal; Francisco FernΓ‘ndez-PΓ©rez; CristΓ³bal Albandea-Moreno; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 2 views

FIGURE 2. Granulocyte count during hospitalization. IFX: infliximab infusion. GR-CSF: introduction of granulocyte stimulating factor.

Infliximab dose intensification in Crohn
Infliximab dose intensification in Crohn's disease
✍ Miguel Regueiro; Benjamin Siemanowski; Kevin E. Kip; Scott Plevy πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 176 KB πŸ‘ 1 views

Background: Crohn's disease (CD) patients who lose response to infliximab may benefit from an increase in dose or decrease in interval between infusions. The aims of this study were to determine the proportion of CD patients who require dose intensification and factors associated with dose intensifi